Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases
Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver....
Gespeichert in:
Veröffentlicht in: | Surgery today (Tokyo, Japan) Japan), 2015-04, Vol.45 (4), p.511-516 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 516 |
---|---|
container_issue | 4 |
container_start_page | 511 |
container_title | Surgery today (Tokyo, Japan) |
container_volume | 45 |
creator | Yamashita, Suguru Hasegawa, Kiyoshi Takahashi, Michiro Arita, Junichi Sakamoto, Yoshihiro Aoki, Taku Sugawara, Yasuhiko Kokudo, Norihiro |
description | Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson’s choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson’s choice two-stage hepatectomy strategy, which provided favorable short-term outcomes. |
doi_str_mv | 10.1007/s00595-014-0953-x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1664192935</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1664192935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-d100b93a26b1242a71960b45e5b5cba52631c7c4950765a13bf47875ed8b0eb43</originalsourceid><addsrcrecordid>eNp9kb1uFTEQhS0EIpfAA9AglzQG_-6u6VAUCFIkGqgt23c215F3vdje_FDxBtS8Hk-CVzdQUk1xvnNGMwehl4y-YZT2bwulSitCmSRUK0HuHqEdk6IjfGDiMdpRLRlhXLMT9KyUa0q5HCh9ik641FIMtN-hnxfJlTT__vGrYH9IwQOut4mUaq8AH2CxFXxN0z0eU8bTGmtYImA777ELMTmbsU8x5QbZiGO4gUZBtc1foODbUA94SXkTbyDMGCaXYvhua0jzO5xh03Aat53Yb5bn6MloY4EXD_MUff1w_uXsglx-_vjp7P0l8ULTSvbtfqeF5Z1jXHLbM91RJxUop7yzineC-d5LrWjfKcuEG2U_9Ar2g6PgpDhFr4-5S07fVijVTKF4iNHOkNZiWNdJprkWqqHsiPqcSskwmiWHyeZ7w6jZejDHHkzrwWw9mLvmefUQv7oJ9v8cfx_fAH4ESpPmK8jmOq15bif_J_UPggyXcQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1664192935</pqid></control><display><type>article</type><title>Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Yamashita, Suguru ; Hasegawa, Kiyoshi ; Takahashi, Michiro ; Arita, Junichi ; Sakamoto, Yoshihiro ; Aoki, Taku ; Sugawara, Yasuhiko ; Kokudo, Norihiro</creator><creatorcontrib>Yamashita, Suguru ; Hasegawa, Kiyoshi ; Takahashi, Michiro ; Arita, Junichi ; Sakamoto, Yoshihiro ; Aoki, Taku ; Sugawara, Yasuhiko ; Kokudo, Norihiro</creatorcontrib><description>Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson’s choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson’s choice two-stage hepatectomy strategy, which provided favorable short-term outcomes.</description><identifier>ISSN: 0941-1291</identifier><identifier>EISSN: 1436-2813</identifier><identifier>DOI: 10.1007/s00595-014-0953-x</identifier><identifier>PMID: 24943807</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Case Report ; Cecal Neoplasms - pathology ; Cecal Neoplasms - surgery ; Embolization, Therapeutic ; Female ; Hepatectomy - methods ; Hepatic Veins - pathology ; Humans ; Liver Neoplasms - diagnostic imaging ; Liver Neoplasms - secondary ; Liver Neoplasms - surgery ; Liver Neoplasms - therapy ; Medicine ; Medicine & Public Health ; Middle Aged ; Portal Vein ; Rectal Neoplasms - pathology ; Rectal Neoplasms - surgery ; Surgery ; Surgical Oncology ; Tomography, X-Ray Computed ; Treatment Outcome</subject><ispartof>Surgery today (Tokyo, Japan), 2015-04, Vol.45 (4), p.511-516</ispartof><rights>Springer Japan 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c390t-d100b93a26b1242a71960b45e5b5cba52631c7c4950765a13bf47875ed8b0eb43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00595-014-0953-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00595-014-0953-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24943807$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamashita, Suguru</creatorcontrib><creatorcontrib>Hasegawa, Kiyoshi</creatorcontrib><creatorcontrib>Takahashi, Michiro</creatorcontrib><creatorcontrib>Arita, Junichi</creatorcontrib><creatorcontrib>Sakamoto, Yoshihiro</creatorcontrib><creatorcontrib>Aoki, Taku</creatorcontrib><creatorcontrib>Sugawara, Yasuhiko</creatorcontrib><creatorcontrib>Kokudo, Norihiro</creatorcontrib><title>Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases</title><title>Surgery today (Tokyo, Japan)</title><addtitle>Surg Today</addtitle><addtitle>Surg Today</addtitle><description>Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson’s choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson’s choice two-stage hepatectomy strategy, which provided favorable short-term outcomes.</description><subject>Case Report</subject><subject>Cecal Neoplasms - pathology</subject><subject>Cecal Neoplasms - surgery</subject><subject>Embolization, Therapeutic</subject><subject>Female</subject><subject>Hepatectomy - methods</subject><subject>Hepatic Veins - pathology</subject><subject>Humans</subject><subject>Liver Neoplasms - diagnostic imaging</subject><subject>Liver Neoplasms - secondary</subject><subject>Liver Neoplasms - surgery</subject><subject>Liver Neoplasms - therapy</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Portal Vein</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectal Neoplasms - surgery</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Tomography, X-Ray Computed</subject><subject>Treatment Outcome</subject><issn>0941-1291</issn><issn>1436-2813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kb1uFTEQhS0EIpfAA9AglzQG_-6u6VAUCFIkGqgt23c215F3vdje_FDxBtS8Hk-CVzdQUk1xvnNGMwehl4y-YZT2bwulSitCmSRUK0HuHqEdk6IjfGDiMdpRLRlhXLMT9KyUa0q5HCh9ik641FIMtN-hnxfJlTT__vGrYH9IwQOut4mUaq8AH2CxFXxN0z0eU8bTGmtYImA777ELMTmbsU8x5QbZiGO4gUZBtc1foODbUA94SXkTbyDMGCaXYvhua0jzO5xh03Aat53Yb5bn6MloY4EXD_MUff1w_uXsglx-_vjp7P0l8ULTSvbtfqeF5Z1jXHLbM91RJxUop7yzineC-d5LrWjfKcuEG2U_9Ar2g6PgpDhFr4-5S07fVijVTKF4iNHOkNZiWNdJprkWqqHsiPqcSskwmiWHyeZ7w6jZejDHHkzrwWw9mLvmefUQv7oJ9v8cfx_fAH4ESpPmK8jmOq15bif_J_UPggyXcQ</recordid><startdate>20150401</startdate><enddate>20150401</enddate><creator>Yamashita, Suguru</creator><creator>Hasegawa, Kiyoshi</creator><creator>Takahashi, Michiro</creator><creator>Arita, Junichi</creator><creator>Sakamoto, Yoshihiro</creator><creator>Aoki, Taku</creator><creator>Sugawara, Yasuhiko</creator><creator>Kokudo, Norihiro</creator><general>Springer Japan</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150401</creationdate><title>Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases</title><author>Yamashita, Suguru ; Hasegawa, Kiyoshi ; Takahashi, Michiro ; Arita, Junichi ; Sakamoto, Yoshihiro ; Aoki, Taku ; Sugawara, Yasuhiko ; Kokudo, Norihiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-d100b93a26b1242a71960b45e5b5cba52631c7c4950765a13bf47875ed8b0eb43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Case Report</topic><topic>Cecal Neoplasms - pathology</topic><topic>Cecal Neoplasms - surgery</topic><topic>Embolization, Therapeutic</topic><topic>Female</topic><topic>Hepatectomy - methods</topic><topic>Hepatic Veins - pathology</topic><topic>Humans</topic><topic>Liver Neoplasms - diagnostic imaging</topic><topic>Liver Neoplasms - secondary</topic><topic>Liver Neoplasms - surgery</topic><topic>Liver Neoplasms - therapy</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Portal Vein</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectal Neoplasms - surgery</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Tomography, X-Ray Computed</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamashita, Suguru</creatorcontrib><creatorcontrib>Hasegawa, Kiyoshi</creatorcontrib><creatorcontrib>Takahashi, Michiro</creatorcontrib><creatorcontrib>Arita, Junichi</creatorcontrib><creatorcontrib>Sakamoto, Yoshihiro</creatorcontrib><creatorcontrib>Aoki, Taku</creatorcontrib><creatorcontrib>Sugawara, Yasuhiko</creatorcontrib><creatorcontrib>Kokudo, Norihiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery today (Tokyo, Japan)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamashita, Suguru</au><au>Hasegawa, Kiyoshi</au><au>Takahashi, Michiro</au><au>Arita, Junichi</au><au>Sakamoto, Yoshihiro</au><au>Aoki, Taku</au><au>Sugawara, Yasuhiko</au><au>Kokudo, Norihiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases</atitle><jtitle>Surgery today (Tokyo, Japan)</jtitle><stitle>Surg Today</stitle><addtitle>Surg Today</addtitle><date>2015-04-01</date><risdate>2015</risdate><volume>45</volume><issue>4</issue><spage>511</spage><epage>516</epage><pages>511-516</pages><issn>0941-1291</issn><eissn>1436-2813</eissn><abstract>Liver resection is recognized as the preferred treatment for patients with colorectal liver metastases (CLM) because it offers long-term survival; it is the only hope for a cure. However, in the majority of cases, liver surgery is contraindicated due to the small volume of the future remnant liver. To extend the surgical indications for CLM, a planned two-stage hepatectomy procedure with portal vein embolization (PVE) was developed specifically for patients with multiple and bilobar CLM. The rationale for performing the procedure was a concern about the possible overgrowth of intrafuture remnant liver lesions following PVE, and it was therefore recommended for all multiple bilobar CLM cases, even when one-stage hepatectomy was technically feasible. We recently performed Hobson’s choice two-stage hepatectomy in two cases for reasons different from those of the original planned two-stage hepatectomy. In the present report, we describe our Hobson’s choice two-stage hepatectomy strategy, which provided favorable short-term outcomes.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>24943807</pmid><doi>10.1007/s00595-014-0953-x</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0941-1291 |
ispartof | Surgery today (Tokyo, Japan), 2015-04, Vol.45 (4), p.511-516 |
issn | 0941-1291 1436-2813 |
language | eng |
recordid | cdi_proquest_miscellaneous_1664192935 |
source | MEDLINE; SpringerLink Journals |
subjects | Case Report Cecal Neoplasms - pathology Cecal Neoplasms - surgery Embolization, Therapeutic Female Hepatectomy - methods Hepatic Veins - pathology Humans Liver Neoplasms - diagnostic imaging Liver Neoplasms - secondary Liver Neoplasms - surgery Liver Neoplasms - therapy Medicine Medicine & Public Health Middle Aged Portal Vein Rectal Neoplasms - pathology Rectal Neoplasms - surgery Surgery Surgical Oncology Tomography, X-Ray Computed Treatment Outcome |
title | Hobson’s choice two-stage hepatectomy for multiple and bilobar colorectal liver metastases with portal vein embolization: report of two cases |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T05%3A19%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hobson%E2%80%99s%20choice%20two-stage%20hepatectomy%20for%20multiple%20and%20bilobar%20colorectal%20liver%20metastases%20with%20portal%20vein%20embolization:%20report%20of%20two%20cases&rft.jtitle=Surgery%20today%20(Tokyo,%20Japan)&rft.au=Yamashita,%20Suguru&rft.date=2015-04-01&rft.volume=45&rft.issue=4&rft.spage=511&rft.epage=516&rft.pages=511-516&rft.issn=0941-1291&rft.eissn=1436-2813&rft_id=info:doi/10.1007/s00595-014-0953-x&rft_dat=%3Cproquest_cross%3E1664192935%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1664192935&rft_id=info:pmid/24943807&rfr_iscdi=true |